CNS Pharmaceuticals, Inc.

NASDAQ:CNSP

0.11 (USD) • At close November 7, 2024
Bedrijfsnaam CNS Pharmaceuticals, Inc.
Symbool CNSP
Munteenheid USD
Prijs 0.113
Beurswaarde 4,201,258
Dividendpercentage 0%
52-weken bereik 0.096 - 137.5
Industrie Biotechnology
Sector Healthcare
CEO Mr. John Michael Climaco Esq., J.D.
Website https://www.cnspharma.com

An error occurred while fetching data.

Over CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of

Vergelijkbare Aandelen

Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp.

LEXX

2.32 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)